SEC Tracker
Get the app

Capstone Therapeutics CAPS

Capstone Therapeutics Corp. and its approximately 60% owned drug development joint venture

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
Exhibit 99.1
Press release
  • Signs a material agreement (1.01)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Capstone Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 5030 and related industry codes: the same peer list as the financial tables.

  1. Aspen Aerogels ASPN public float $480M, Jun 30, 2025
  2. Olenox Industries OLOX public float $8M, Jun 30, 2026
  3. Boise Cascade BCC public float $3.2B, Jun 30, 2025
  4. QXO QXO public float $13.7B, Jun 30, 2025
  5. SMJ International Holdings SMJF